- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00922805
Fiber Use in Pediatric Short Bowel Syndrome
Soluble Fiber Use in Pediatric Short Bowel Syndrome
Short bowel syndrome (SBS) is a form of disease that results from removal of a significant portion of the intestine leading to poor nutrient absorption. Infants with short bowel syndrome suffer from diarrhea and poor growth. The care of these infants is limited by the lack of effective therapies.
Soluble fiber (guar gum) is an indigestible form of sugar that is mostly contained in fruits and vegetables. Soluble fiber can reduce the severity and duration of persistent (constant) diarrhea in children.
The purpose of this research study is to evaluate the many effects of fiber added in the diet of infants with SBS
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Short bowel syndrome (SBS) is a form of disease that results from removal of a significant portion of the intestine leading to poor nutrient absorption. Infants with short bowel syndrome suffer from diarrhea and poor growth. The care of these infants is limited by the lack of effective therapies. As the intestine tries to grow back some of its length, a process that can take many months, these infants become dependent on intravenous (IV) nutrition in order to survive. Liver disease and sepsis (a blood stream infection) are common complications of IV nutrition and are the two most common causes of death in this population. Therefore, clinicians have tried different ways to improve feeding and shorten the amount of time of IV nutrition, for example continuous feedings through the intestine, use of partly digested formulas and change in diet.
Soluble fiber (guar gum) is an indigestible form of sugar that is mostly contained in fruits and vegetables. Soluble fiber can reduce the severity and duration of persistent (constant) diarrhea in children.
The purpose of this research study is to evaluate the many effects of fiber added in the diet of infants with SBS.
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Arkansas
-
Little Rock, Arkansas, United States, 72202
- Arkansas Children's Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Pediatric infants (less than 1 y of age) who
- Have Short Bowel Syndrome defined by a history of congenital or surgical loss of intestinal absorptive function resulting in parenteral nutrition dependency of longer than 30 days;
- Are receiving at least 20% of their caloric needs from enteral nutrition and have been on enteral nutrition for at least 1 week following intestinal resection;
- Have increased stool output as manifested by watery stools (3-12/day) and increased ostomy output (20-50 cc/kg/day);
- Have not received antibiotics, probiotics or prebiotics for 2 weeks prior to study entry;
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: fiber-enriched formula then fiber-free formula
Subjects first receive a fiber-enriched formula for one week but then will be crossed over and receive a fiber-free formula
|
guar gum (20 g/l of formula) for one week
Other Names:
|
|
Active Comparator: fiber-free formula then fiber-enriched formula
Subjects receive first formula only then will be crossed over and receive a fiber-enriched formula
|
guar gum (20 g/l of formula) for one week
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Soluble fiber supplementation, as a short chain fatty acid precursor, will improve intestinal integrity of infants with SBS
Time Frame: 4 weeks
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Soluble fiber supplementation will improve enteral energy intake of infants with SBS
Time Frame: 4 weeks
|
4 weeks
|
Collaborators and Investigators
Investigators
- Principal Investigator: Juliana C Frem, MD, University of Arkansas
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CUMG-108061
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Short Bowel Syndrome
-
Marathon Pharmaceuticals, LLCWithdrawnShort Bowel Syndrome | Short Gut Syndrome | SBS | Short Gut | Short BowelUnited States
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingShort Bowel Syndrome (SBS)
-
Meyer Children's Hospital IRCCSRecruiting
-
TakedaRecruitingShort Bowel Syndrome (SBS)China
-
Jinling Hospital, ChinaRecruitingIntestinal Failure | Short Bowel Syndrome (SBS)China
-
Central Hospital, Nancy, FranceBeaujon Hospital; Société Francophone Nutrition Clinique et MétabolismeUnknownSBS - Short Bowel SyndromeFrance
-
TakedaCompletedShort Bowel Syndrome (SBS)Brazil
-
TakedaCompletedShort Bowel Syndrome (SBS)Canada
-
GlyPharma TherapeuticsVectivBio AGCompletedSBS - Short Bowel SyndromeDenmark
-
Zealand PharmaEnrolling by invitationShort Bowel Syndrome (SBS)Germany, United States, Belgium, Canada, France, Poland, United Kingdom
Clinical Trials on guar gum
-
Hospital de Clinicas de Porto AlegreCompletedMetabolic Syndrome | AlbuminuriaBrazil
-
Imperial College LondonCompleted
-
King's CollegeCompletedIron-deficiency | Iron Deficiency Anemia | Iron Deficiency (Without Anemia)United States
-
Wageningen UniversityCompleted
-
IRCCS San Raffaele RomaCompleted
-
Fu Jen Catholic University HospitalRecruitingMicrobial Colonization | COPD | Respiratory Tract DiseaseTaiwan
-
The University of Hong KongRecruiting
-
Eskisehir Osmangazi UniversitySehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research HospitalCompletedConstipation - FunctionalTurkey (Türkiye)
-
University of DundeeChief Scientist Office of the Scottish GovernmentWithdrawn
-
UMC UtrechtCompleted